Found 136 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 2
Interventional
This study is looking for individuals at least 18 years of age with severe alopecia areata (AA). Alopecia areata is a common hair loss condition that results in patches of hair loss on the scalp, eyebrows, eyelashes or on any other hair-bearing region of the body. Alopecia areata can affect …
18 years or above
All genders
Phase 3
Interventional
This double-blind, randomized, placebo-controlled, multinational, multicenter, parallel-group, Phase 3, 2-arm, study will investigate the efficacy and safety of belumosudil compared with placebo, both administered on top of azithromycin and standard-of-care regimen of immunosuppression in male or female participants at least 1 year after bilateral lung transplant, who are at least …
18 years - 65 years
All genders
Phase 1
Interventional
SAR439459 is a human anti-Transforming growth factor β (TGFβ) monoclonal antibody. This phase 1 clinical study investigates the safety, tolerability, and activity of a single dose of SAR439459 in adult participants with OI. Participants will receive a single IV dose of SAR439459 with safety, pharmacokinetic (PK), and pharmacodynamic (PD) assessments …
Transgender
Phase 2/3
This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyone should have the opportunity to take part in clinical trials. It is important to include people who have been historically under-represented in clinical trials. Sanofi is committed to inclusivity in our studies. If …
18 years - 75 years
All genders
Phase 2
This is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for further clinical development will be based on the multiple efficacy, safety and PK parameters.The …
18 years - 85 years
All genders
Phase 2
This study is looking for individuals ages 18 to 85 with bronchiectasis who require treatment in addition to their current therapies.   Bronchiectasis is a long-lasting lung disease characterized by the enlargement of the air passages inside the lungs due to weakening of the airway vessel wall, which leads to symptoms …
10 years - 100 years
Accepts healthy volunteer
All genders
Phase 3
Sanofi Test Website Minimal-Image - Brief summary
100 years or below
All genders
In this blinded prospective randomized control trial the researchers will investigate the impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal nerve stimulator. The device will be applied to participants after consent and induction …
18 years or above
Female
Adnexal cysts or pseudocysts are a common finding on transvaginal ultrasound, especially in premenopausal women. Due to the size of some cysts, they may cause discomfort. Moreover, a genuine risk of ovarian torsion presents when these lesions grow.During the last decades, great advancements have been made in the correct differentiation …
42 days - 50 years
Accepts healthy volunteer
All genders
Phase 1/2
Primary Objective: To describe the safety profile of the SP MenB vaccine formulations and the 2 licensed MenB comparator vaccines in healthy adults, adolescents, toddlers and infants, when administered alone (Stages 1-4) or concomitantly with MenQuadfiTM (MenACYW conjugate vaccine) (for Stages 2-4 only), and with age-appropriated routine pediatric vaccines (for …
21 - 30 of 136